Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.

Clinical differentiation of parkinsonian syndromes such as the Parkinson variant of multiple system atrophy (MSA-P) and progressive supranuclear palsy (PSP) from Parkinson's disease is difficult in the early stage of the disease. In order to identify objective markers for differential diagnosis, we studied these three groups of patients with diffusion-weighted MRI (DWI). Sixteen MSA-P patients, 16 with PSP, 16 with Parkinson's disease and 15 healthy volunteers were studied. Regional apparent diffusion coefficients (rADC) were determined in different brain regions including basal ganglia, thalamus, white matter, pons and middle cerebellar peduncles (MCPs). rADC calculated in the MCP completely differentiated MSA-P patients (median: 0.93 x 10(-3) mm2/s) from PSP patients (median: 0.82 x 10(-3) mm2/s, P < 0.001), Parkinson's disease patients (median: 0.79 x 10(-3) mm2/s, P < 0.001) and healthy volunteers (median: 0.81 x 10(-3) mm2/s, P < 0.001). Other regions considered showed an overlapping among groups. DWI discriminates MSA-P from PSP and Parkinson's disease and healthy volunteers on the basis of MCP rADC values. These in vivo results confirm the pathological findings that the majority of MSA-P patients have moderate or severe degenerative changes not only in the nigrostriatal but also in the olivopontocerebellar systems. Our findings indicate that, in order to substantially contribute to the in vivo differential diagnosis of MSA-P, PSP and Parkinson's disease, rADC measurements should not be limited to the basal ganglia but should also include the MCP.

[1]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[2]  Francesco Federico,et al.  Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .

[3]  P. Grenier,et al.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. , 1986, Radiology.

[4]  James R. Moore,et al.  Correction for distortion of echo‐planar images used to calculate the apparent diffusion coefficient , 1996, Magnetic resonance in medicine.

[5]  Z. Wszolek,et al.  New and reliable MRI diagnosis for progressive supranuclear palsy , 2006, Neurology.

[6]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[7]  N P Quinn,et al.  Olivopontocerebellar pathology in multiple system atrophy , 1996, Movement disorders : official journal of the Movement Disorder Society.

[8]  B. Drayer,et al.  Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. , 2002, Archives of neurology.

[9]  W. Bernstein.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[10]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[11]  R A Crowther,et al.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.

[12]  Christian Kremser,et al.  Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.

[13]  Nick C Fox,et al.  Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy , 2005, Neurology.

[14]  B. Barbiroli,et al.  Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease , 1999, Movement Disorders.

[15]  Osamu Onodera,et al.  Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging , 2004, Journal of Neurology.

[16]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[17]  R. Turner,et al.  Diffusion MR imaging: clinical applications. , 1992, AJR. American journal of roentgenology.

[18]  S. Nakamura,et al.  Characteristic magnetic resonance imaging findings in Machado-Joseph disease. , 1998, Archives of neurology.

[19]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[20]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[21]  M. Weiger,et al.  Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics , 2004, Neurology.

[22]  F. Tison,et al.  Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD , 2003, Journal of Neural Transmission.

[23]  Yoav Ben-Shlomo,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Clinical Autonomic Research.

[24]  A J Lees,et al.  Clinical usefulness of magnetic resonance imaging in multiple system atrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.

[25]  J. Winn,et al.  Brain , 1878, The Lancet.

[26]  Y. Hashizume,et al.  Neuronal cell loss of the striatonigral system in multiple system atrophy , 1993, Journal of the Neurological Sciences.

[27]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[28]  C. Marsden,et al.  Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.

[29]  B. Snow,et al.  Criteria for diagnosing Parkinson's disease , 1992, Annals of neurology.

[30]  R A Zimmerman,et al.  Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. , 1990, Radiology.

[31]  P. Mansfield.  Multi-planar image formation using NMR spin echoes , 1977 .

[32]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[33]  Y Ben-Shlomo,et al.  Clinical features and natural history of progressive supranuclear palsy , 2003, Neurology.

[34]  S. Tsuji,et al.  Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. , 1998, Neuroscience letters.

[35]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[36]  G. Bydder,et al.  Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline , 2001, Journal of Neural Transmission.

[37]  D. Purdie.  Statistical Methods in Medical Research, 4th edn , 2003 .

[38]  L Solymosi,et al.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.

[39]  N P Quinn,et al.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.

[40]  S. Nakamura,et al.  Apparent diffusion coefficient measurements in progressive supranuclear palsy , 2000, Neuroradiology.

[41]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[42]  C Kremser,et al.  Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.

[43]  M. Folstein,et al.  Population-based norms for the Mini-Mental State Examination by age and educational level. , 1993, JAMA.

[44]  K. Double,et al.  Regional brain atrophy in idiopathic parkinson's disease and diffuse Lewy body disease. , 1996, Dementia.

[45]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[46]  A M Owen,et al.  The cognitive neuropsychology of Parkinson's disease: a functional neuroimaging perspective. , 1999, Advances in neurology.

[47]  J. E. Tanner,et al.  Spin diffusion measurements : spin echoes in the presence of a time-dependent field gradient , 1965 .